tradingkey.logo

Aclarion Inc

ACONW
View Detailed Chart

0.028USD

-0.001-2.07%
Close 08/01, 16:00ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

Aclarion Inc

0.028

-0.001-2.07%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.07%

5 Days

+Infinity%

1 Month

-20.45%

6 Months

-43.20%

Year to Date

+42.00%

1 Year

-28.64%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(4)
Neutral(2)
Buy(6)
Indicators
Sell(2)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-0.000
Sell
RSI(14)
51.152
Neutral
STOCH(KDJ)(9,3,3)
70.230
Buy
ATR(14)
0.012
High Vlolatility
CCI(14)
45.218
Neutral
Williams %R
16.959
Overbought
TRIX(12,20)
-1.207
Sell
StochRSI(14)
98.578
Buy
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
0.017
Buy
MA10
0.023
Buy
MA20
0.025
Buy
MA50
0.027
Buy
MA100
0.034
Sell
MA200
0.033
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
Ticker SymbolACONW
CompanyAclarion Inc
CEOMr. Brent Ness
Websitehttps://aclarion.com/
KeyAI